Jon Amund Kyte

2.3k citations
49 papers · 1.6k indexed · h-index 21
Topics
Cancer Immunotherapy and Biomarkers (23 papers)Immunotherapy and Immune Responses (22 papers)CAR-T cell therapy research (18 papers)
Partner nations
NorwayDenmarkBelgium

In The Last Decade

Jon Amund Kyte

44 papers receiving 1.5k citations

Peers

Jon Amund Kyte
Comparison fields: 5 of 83
  • Immunology 947
  • Oncology 921
  • Molecular Biology 636
  • Genetics 169
  • Pulmonary and Respiratory Medicine 141
Replace Duygu Sari with:
Duygu Sari United States
Tetsuro Sasada Japan
Nikolina Bąbała Netherlands
Bruno L. Cadilha Germany
Charles H. Maris United States
Daisuke Sugiura Japan
Eva Ellebæk Denmark
Jesse M. Zaretsky United States
Grégory Verdeil Switzerland
Vittore Cereda Italy
Jon Amund Kyte relative to Duygu Sari United States Duygu Sari's profile →
Citations per field
00.5×1.5×2.1×
Duygu Sari · 1×
Citations per year

Countries citing papers authored by Jon Amund Kyte

Since Specialization
Citations

This map shows the geographic impact of Jon Amund Kyte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Amund Kyte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Amund Kyte more than expected).

Fields of papers citing papers by Jon Amund Kyte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Amund Kyte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Amund Kyte. The network helps show where Jon Amund Kyte may publish in the future.

Co-authorship network of co-authors of Jon Amund Kyte

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Amund Kyte. A scholar is included among the top collaborators of Jon Amund Kyte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Amund Kyte. Jon Amund Kyte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 8
4 4
5 9
6 11
7 0
8 20
9 51
10 33
11 1
12 5
13 84
14 94
15 92
16 131
17 72
18 162
19 75
20 50

About Jon Amund Kyte

Jon Amund Kyte is a scholar working on Oncology, Immunology and Biotechnology, having authored 49 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (23 papers), Immunotherapy and Immune Responses (22 papers) and CAR-T cell therapy research (18 papers). The work is most often cited by research in Immunology (947 citations), Oncology (921 citations) and Biotechnology (112 citations). Jon Amund Kyte has collaborated with scholars based in Norway, Denmark and Belgium. Frequent co-authors include Gustav Gaudernack, Steinar Aamdal, Gunnar Kvalheim, Svein Dueland, Kari Lislerud, Ludvig A. Munthe, Sissel Trachsel, M. Häuser, Lijun Mu and Bjørn Naume. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026